SABCS 2024: Expert on Site
SABCS 2024: Expert on Site
Advertisement
The Evolving Standard of Care in Metastatic Triple-Negative Breast Cancer
Karine Tawagi, MDSABCS 2024: Expert on Site | December 19, 2024
Dr. Adam Brufsky provides an overview on the best treatments in metastatic TNBC space, including Trodelvy.
View More
The Main Obstacles Associated With Treating Metastatic Triple-Negative Breast Cancer
Karine Tawagi, MDSABCS 2024: Expert on Site | December 19, 2024
Drs. Karine Tawagi and Adam Brufsky discuss the challenges of navigating treatment in patients with mTNBC.
View More
EZH2 Inhibition in Triple-Negative Breast Cancer Reduces Tumor Growth
Rob DillardSABCS 2024: Expert on Site | December 19, 2024
A study sought to assess if a treatment combination inhibits tumor growth and metastasis in TNBC.
Read More
Analyzing the Management of Neutropenia and Effectiveness of Trodelvy in Patients With mTNBC
Rob DillardSABCS 2024: Expert on Site | December 18, 2024
Sacituzumab govitecan-related neutropenia can be effectively treated using G-CSF prophylaxis in patients with mTNBC.
Read More
Advertisement
Advertisement
Advertisement
Latest News

Genetic Classification Model Differentiates MDS Stem, Progenitor Cells from Healthy Bone Marrow

December 20, 2024

FDA Grants Breakthrough Therapy Designation to Sacituzumab Govitecan for Second-Line Treatment of ES-SCLC

December 20, 2024

Genetic Study Uncovers Potential Therapy-Actionable Transcription Factors in MDS

December 20, 2024

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Contribute

    Contact Us

    Our Network

    MashupMD

    Blood Cancers Today

    Cancer Nursing Today

    GU Oncology Now

    Urban Health Today

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |